Welcome! Thank you for connecting to Helsinn’s LinkedIn profile. Helsinn would like to emphasize and make you aware that due ... to the highly regulated nature of the pharma industry, we cannot engage with you online in sensitive discussions or topics concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional. Helsinn is a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically investing in a fully integrated targeted therapy structure to develop, manufacture and commercialize small molecules in precision medicine with higher market potential, thanks to a consolidated track record, a solid revenue stream in B2B and strong cash flow and cash position. Since 1976, Helsinn has been improving the lives of patients, guided by core family values of respect, integrity and quality, through a unique integrated licensing business model, and by collaborating with success in about 190 countries with long-standing partners who share our values. If you are interested in joining Helsinn Healthcare or one of our affiliates, please visit the following website: helsinn.com. If you are interested in applying for an open position, please submit your application only through the appropriate country portal you will find in the website under “Working for Helsinn”. Any other sources of communications are unauthorized, and we discourage candidates from replying to suspect employment offers received through unofficial channels. If you are experiencing problems or have questions, please contact for Switzerland info-HHC@helsinn.com, for the U.S. HTU-HR@helsinn.com, for Ireland info-hbp@helsinn.com. [These emails are NOT an application channel: CVs and sensitive information sent inappropriately to the above emails will NOT be considered or processed, and will be DELETED] read more